Freestone Grove Partners’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$585K Sell
7,189
-3,322
-32% -$263K ﹤0.01% 629
2026
Q1
$768K Sell
10,511
-2,964
-22% -$231K 0.01% 527
2025
Q4
$1.03M Buy
13,475
+4,198
+45% +$317K 0.01% 464
2025
Q3
$716K Hold
9,277
0.01% 485
2025
Q2
$780K Buy
+9,277
New +$812K 0.01% 464

Other funds holding IOSP

Freestone Grove Partners's IOSP Position: Q2 2026 in Review

Freestone Grove Partners reduced its Innospec (IOSP) stake by 32% in Q2 2026, selling an estimated $263K and leaving 7,189 shares worth $585K. The position accounts for ﹤0.01% of the portfolio, ranked #629.

Freestone Grove Partners first reported a position in IOSP in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.03M in Q4 2025. 282 funds tracked by Wall St. Rank hold IOSP as of Q2 2026.

  • Freestone Grove Partners held 7,189 shares of Innospec worth $585K as of Q2 2026.
  • Freestone Grove Partners sold 3,322 Innospec shares in Q2 2026, an estimated $263K.
  • Innospec made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #629 holding.
  • Freestone Grove Partners first reported a position in Innospec in Q2 2025 and has held it in 5 quarters since.
  • Freestone Grove Partners's Innospec position peaked at $1.03M in Q4 2025.
  • 282 funds tracked by Wall St. Rank held Innospec as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.